Trump says pharmaceutical tariffs may be coming: What to know

Pharmaceutical companies are facing a potential hit as President Trump considers imposing tariffs on pharmaceutical imports, causing stock prices to fall. Companies like Johnson & Johnson, Eli Lilly, and Merck are already investing billions in expanding their manufacturing in the US in anticipation of the tariffs. European-based companies like AstraZeneca and GSK are also monitoring the situation closely, as trade groups warn of a potential shift to the US market if the EU does not strengthen its regulations.

Full Article